<?xml version="1.0" encoding="UTF-8"?>
<ref id="B88-pharmaceutics-12-00171">
 <label>88.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahajan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Aalinkeel</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Law</surname>
    <given-names>W.-C.</given-names>
   </name>
   <name>
    <surname>Reynolds</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Nair</surname>
    <given-names>B.B.</given-names>
   </name>
   <name>
    <surname>Sykes</surname>
    <given-names>D.E.</given-names>
   </name>
   <name>
    <surname>Yong</surname>
    <given-names>K.-T.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Prasad</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Schwartz</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Anti-HIV-1 nanotherapeutics: Promises and challenges for the future</article-title>
  <source>IJN</source>
  <year>2012</year>
  <fpage>5301</fpage>
  <pub-id pub-id-type="doi">10.2147/IJN.S25871</pub-id>
  <?supplied-pmid 23055735?>
  <pub-id pub-id-type="pmid">23055735</pub-id>
 </element-citation>
</ref>
